Cytokine profile of liver-infiltrating CD4(+) T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction
S. Itoh et al., Cytokine profile of liver-infiltrating CD4(+) T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction, J GASTR HEP, 15(4), 2000, pp. 443-451
Background and Methods: We have previously reported that CD4(+) T cells ind
uced primary biliary cirrhosis (PBC)-like hepatic lesions in mice with graf
t-versus-host reaction due to major histocompatibility complex class II dis
parity. To clarify the relationship between the cytokine profile produced b
y CD4(+) T cells and the formation of hepatic lesions, we sorted CD4(+) T c
ells from the liver by using flow cytometry and examined their cytokine mRN
A expression at various times after GVHR induction. We also examined the as
sociated changes in the serum levels of antimitochondrial antibodies (AMA).
Results: Histologically, the infiltration of CD4(+) T cells around the bile
ducts was observed from day 5, and the lesions deteriorated gradually unti
l day 14. On day 14, CD8(+), B220(+) and Mac-1(+) cells, as well as CD4(+)
T cells were seen around the bile ducts. In the liver-infiltrating CD4(+) T
cells, the expression level of interferon-gamma (IFN-gamma) mRNA was obser
ved to increase at an early phase (day 3), whereas that of interleukin (IL)
-10 mRNA was elevated at a later phase (day 14). The elevation of IFN-gamma
mRNA expression at an early phase before the appearance of non-suppurative
destructive cholangitis suggests that IFN-gamma may be related to the path
ogenesis of PBC in this model. Serum levels of AMA on day 14 were significa
ntly higher than those on day 5. Interleukin-10 was considered to stimulate
antibody production, to show an inhibitory effect upon the function of T h
elper 1 cells, and to inhibit fibrosis.
Conclusions: Interferon-gamma may play an important role in the pathogenesi
s of this model. Moreover, delayed expression of IL-10 mRNA may control PBC
-like hepatic lesions. (C) 2000 Blackwell Science Asia Pty Ltd.